[Clinico-immunological substantiation of the use of rifampicin in the combined therapy of adults and adolescents with destructive pulmonary tuberculosis]. 1989

E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova

The effect of various doses of rifampicin on intensity of rosette formation was studied, and the immunological criteria for selective use of the drug in combined specific chemotherapy of extended destructive tuberculosis of the lungs were determined. It was shown that differential use of rifampicin with an account of its administration multiplicity and route promoted a decrease in the hospitalization terms and increased rate of discontinuation of tubercle bacilli isolation and cavern healing. The clinicoroentgenological findings were confirmed by the immunological tests characterizing various elements of the immunity system in patients.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1986, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
December 1988, Vrachebnoe delo,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1974, Terapevticheskii arkhiv,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 2012, Vestnik otorinolaringologii,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1971, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1994, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1987, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1987, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1995, Problemy tuberkuleza,
E F Chernushenko, and L S Kogosova, and I G Il'nitskiĭ, and A I Petrashenko, and S I Goncharova
January 1971, Problemy tuberkuleza,
Copied contents to your clipboard!